How to Buy Century Therapeutics Stock
Century Therapeutics Inc
Century Therapeutics, Inc. , a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies.
Century Therapeutics stock last closed at $0.50, up 1.2% from the previous day, and has decreased 83.48% in one year. It has underperformed other stocks in the Biotechnology industry by 0.06 percentage points. Century Therapeutics stock is currently +47.37% from its 52-week low of $0.34, and -86.38% from its 52-week high of $3.70.
At the moment, there are 86.05M IPSC shares outstanding. The market value of IPSC is $43.37M. In the last 24 hours, 886,602 IPSC shares were traded.
How to Buy Century Therapeutics Stock
Not sure how to invest in Century Therapeutics stock? Here's how.
- Figure out where to buy Century Therapeutics stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Century Therapeutics stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Pick your method of payment and add your info.
- Analyze Century Therapeutics stock: The Century Therapeutics ticker symbol is IPSC. Is Century Therapeutics stock a good investment? Should you buy shares of IPSC? How do IPSC's underlying business fundamentals look? Do top analysts think Century Therapeutics is a good buy? Why has IPSC's stock price moved recently? (Hint: Our stock research tools can help you figure out if IPSC is a good stock to buy).
- Place your IPSC buy order: Decide if you will purchase IPSC shares at the current market price or use a limit order to purchase IPSC stock at a particular price.
- Get the latest news on your IPSC position: Create a watchlist to keep tabs on your position in Century Therapeutics stock.
Step 1: Figure out where to buy Century Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy IPSC shares.
Our favorite brokerage: eToro
We believe that eToro is the best place to buy stocks. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world markets: From Tech to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal details so you can invest in IPSC stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to open your new brokerage account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have finished signing up on the best stock investing app, you can securely and quickly fund your account:
Watch the walkthrough below if you need help depositing funds into your new brokerage account.
Step 4: Analyze Century Therapeutics stock
After you have selected the best place to buy Century Therapeutics stock, it's important to research their stock prior to buying, so you actually wrap your head around the risk and upside.
Century Therapeutics shares data
Century Therapeutics Due Diligence Checks
WallStreetZen was built to help everyday investors do more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on IPSC's stock page.
How is IPSC stock valued?
You can use many financial metrics, analyses, models, and charts to gauge IPSC's intrinsic value.
Using relative valuations methods:
- IPSC could be undervalued based on its P/B ratio of 0.27x, relative to Biotechnology industry P/B ratio of 4.37x
You can do additional valuation research on IPSC's stock here.
IPSC Financial Health Summary
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the IPSC balance sheet.
- Total IPSC debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the IPSC balance sheet.
- IPSC has cash burn of 110289000. It has sufficient cash and short-term investments to cover this for at least one year.
- IPSC has $192.06M in cash and short term investments. This is enough to cover its annual cash burn of $110.29M.
Negative Financial Indicators:
- IPSC has a relatively high debt to equity ratio of 1.19.
- IPSC profit margin has gone up by 41.94 percentage points in the past year, but the company is still unprofitable.
Is IPSC stock a Buy, Hold, or Sell, according to analysts?
Out of 4 sell side analysts who give ratings on IPSC, the consensus analyst rating on IPSC is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Century Therapeutics stock forecast page.
IPSC Momentum
How is IPSC performing as a company?
Last year, IPSC revenue was $6.59M. During the past 2 year, IPSC's revenue has gone up by 12.58% per year. This was slower than the Biotechnology industry average of 45.47%.
Learn more about IPSC's earnings and revenue performance here.
Who is buying/selling IPSC?
In the last year, insiders at IPSC have sold more shares than they have bought.
Douglas Carr, SVP Finance Operations of IPSC, was the latest IPSC insider to sell. They sold $762.60 worth of IPSC shares on Mar 10, 2025.
Research more about who owns IPSC stock here.
Does IPSC provide a stable income stream?
No, Century Therapeutics doesn't provide an income stream by paying out dividends.
IPSC Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your IPSC buy order
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount, place a limit order.
Hit the Open button and your broker will place your order.
If you require additional help buying stocks on eToro, watch the helpful video below:
Step 6: Get the latest news on your IPSC position
Now that you own some IPSC stock, you'll want to keep up with your shares.
Start a watchlist to get notified of important updates regarding your IPSC stock.
IPSC Feed
How to Buy Stock in Century Therapeutics
To summarize, here are the 6 steps you need to take to buy Century Therapeutics stock right now:
- Figure out where to buy Century Therapeutics stock
- Create your brokerage account
- Fund your brokerage account
- Analyze Century Therapeutics stock
- Place your IPSC buy order
- Get the latest news on your IPSC position
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep tabs on your new investment in Century Therapeutics, click below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.